Related Experiment Video

Updated: Jun 6, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Management of Gram-negative and fungal endocarditis

Emanuele Durante-Mangoni1, Marie-Françoise Tripodi, Rosina Albisinni

  • 1University of Naples SUN, Monaldi Hospital, Napoli, Italy.

International Journal of Antimicrobial Agents
|December 7, 2010
PubMed

Insights

Gram-negative bacteria and fungi rarely cause infective endocarditis but lead to severe disease with high mortality. Management involves complex antimicrobial and surgical decisions for these rare, resistant infections.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Microbiology

Background:

  • Infective endocarditis (IE) is typically caused by Gram-positive bacteria.
  • Gram-negative bacteria (<4%) and fungi (<1.5%) are rare causes of IE.
  • These rare IE cases are severe, often nosocomial, and associated with high mortality.

Purpose of the Study:

  • To review recent literature on Gram-negative and fungal IE.
  • To discuss current management strategies, including antimicrobial and surgical approaches.
  • To present institutional experience with Gram-negative IE.

Main Methods:

  • Literature review of recent data on Gram-negative and fungal IE.
  • Analysis of challenges in antimicrobial therapy.
  • Discussion of surgical decision-making in complex cases.
  • Presentation of single-center experience.

Main Results:

  • Gram-negative and fungal IE are severe, rare infections with high complication and mortality rates.
  • Antimicrobial resistance and treatment challenges are significant.
  • Surgical intervention is often complex and debated.

Conclusions:

  • Management of Gram-negative and fungal IE requires tailored, multidisciplinary approaches.
  • Addressing antimicrobial resistance and optimizing surgical timing are critical.
  • Further research and standardized guidelines are needed for these challenging cases.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...